This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Crear y nutrir tu red: El arte de construir relaciones mutuametne beneficiosas a largo plazo
Neill, Conor; Ferraro, FabrizioTechnical Note SMN-676Entrepreneurship, Leadership and People ManagementEl networking es el arte de construir relaciones mutuamente beneficiosas a largo plazo, y esta nota describe qué pueden hacer las redes sociales y qué es, y qué no, el networking. Además, te ofrecemos siete sugerencias para comenzar a construir tu propia red de contactos.Starting at €8.20
-
¿Un regalo del cielo El giro estratégico de J. C. Penney
Maoret, Massimo; Martin Romano, Cristina; Ferraro, FabrizioCase SM-1665Innovation and Change, Leadership and People Management, StrategyEl caso analiza la formulación e implementación del giro estratégico de J. C. Penney, un importante minorista estadounidense, por parte de Ron Johnson, ejecutivo destacado que anteriormente había liderado la creación y expansión de Apple Store. El giro es audaz y de gran alcance, lo que plantea interrogantes sobre si funcionará o no.Starting at €8.20
-
Digital Competition in Fashion & Luxury Goods: YNAP versus Farfetch - Teaching Note
Sastre Boquet, Isaac; Ferraro, Fabrizio; Baldo, AndreaTeaching Note SMT-120-EInnovation and Change, Service and Operations Management, StrategyIn 2015, Yoox CEO Federico Marchetti spearheaded the deal of a lifetime, merging Yoox Group with Net-a-Porter Group. But in 2017, two years later, the financial community was expecting him to deliver results. Moreover, a new threat had emerged. Farfetch, a luxury platform that aggregated the inventories of over 500 luxury boutiques all over the world, had reached US$800 million in sales after less than 10 years of operations, with a staggering 70...Starting at €0.00
-
Alvogen: Scaling Entrepreneurship, Teaching Note
Kerr, William R.; Isenberg, Daniel J.Teaching Note HBS-820020-EEntrepreneurshipTeaching note for case 819038.Starting at €0.00
-
Visualizing Your Social Network
Ferraro, Fabrizio; Tortoriello, MarcoTechnical Note SMN-687-EStrategyThe technical note provides different options for visualizing one's social network. Drawing a picture of your social network, and of the broader social network in your company, might help you go beyond a simplistic view of what your contacts are (Who do you know?) and think about how the people in your company are connected to each other (your indirect contacts).Starting at €8.20
-
Leadership at WildChina (B)
Isenberg, Daniel J.; Spence, Shirley M.Case HBS-807128-EEntrepreneurshipSupplements the (A) case.Starting at €5.74
-
The Agile CEO: Strategies for Success
Andreu i Civit, Rafael; Ricart, Joan Enric; Ferraro, Fabrizio; Cassiman, Bruno; Tushman, Michael L.Dossier DOS-23-EInnovation and Change, Leadership and People Management, StrategyThis dossier will help you engage with the challenges of our times, with an agenda for CEOs to shape the path ahead.Starting at €15.00
-
ESG is dead, long live ESG
Ferraro, Fabrizio; Alex EdmansArticle ART-3449-EFinance, StrategyESG factors are so important, which is an argument for why they shouldn?t be treated as anything special. Fabrizio Ferraro digs into the debate with Alex Edmans.Starting at €8.20
-
Vueling: The New Generation Airline (A)
Mitchell, Jordan; Ferraro, FabrizioCase SM-1561-EEntrepreneurship, Innovation and Change, StrategyVueling (A) case follows start-up and growth of a Spanish low-cost carrier from 2004 until 2007. Barcelona-based Vueling set out to offer "high quality at low price" to travellers in South-Western Europe. The case describes the strategy and competitive situation, Vueling's business model, and the challenges the company faced in an increasingly competitive environment.Starting at €8.20
-
Robert Wessman and Actavis' "Winning Formula"
Isenberg, Daniel J.Case HBS-808127-EEntrepreneurshipTo maximize their effectiveness, color cases should be printed in color. Robert Wessman took over Actavis in 1999 when it was a failing 90-person domestic generic pharmaceutical maker in Iceland. Within 7 years he had brought Actavis to number 5 worldwide, with 11,000 people, active in 40 countries, global manufacturing, and $1.6 billion. The case explores the reasons for the success of this global venture.Starting at €8.20